2. The authors conclude: "Therefore, the effect of the W266A mutation on FAK:FAK FRET was best explained by the disruption of FAK dimerization, and not by a decreased recruitment to FAs" but the data appear to support the exact opposite conclusion. The authors examine for recruitment to Fas by comparing location of HA-tagged FAK or W266A-FAK in FAK-null fibroblasts. The images in Fig. 2C vs. D, as well as in 2E show nearly complete abrogation of FA localization by this mutation and a transfer to the cytoplasm as indicated by the higher Z section. These results indicate a major decrease in recruitment to FAs.
3. Another, possibly related, inconsistency is between Fig. 2F and Figs. C-E. The latter show nearly complete loss of localization, while 2F shows a rather modest reduction of about one-third. Why this major discrepancy? Perhaps the authors need to show more representative images and clarify to readers that there is actually not much effect on localization (to be able to reach the conclusion questioned in point #2 above).
4. The LD4 peptide experiment is quite interesting, but it is not clear that the control peptide provides a sufficient control, since it is shorter and has no apparent relationship to the experimental peptide. Is its overall charge the same, or was there some other reason for its choice? A better control would be a scrambled-sequence peptide.
5. The section on page 8 jumping from the FERM:FERM interaction to the FAK interaction was initially quite confusing. The authors should emphasize the switch in types of molecule being studied, since it is only after reaching the conclusion on page 9 that the data showing extremely poor affinity of FERM:FERM interaction makes sense when compared to the claims of FAK:FAK dimerization, the existence of which would require considerably higher affinity. Hidden in the Discussion is an estimate for the latter of 0.1-0.5 uM, which still seems rather poor -how likely is it that one could see retention of homodimers after the long time needed for electrophoresis or gel filtration using dimers with this rather low affinity? It is possible that using a high molar concentration of FAK would help, but these concentrations are never indicated. Alternatively, is there a very low off rate? (but which would need to be accompanied by a slow on rate)
Other points:
7. The authors should clarify how they "selected only cells for analysis that showed FAK expression levels less than 2-fold those of endogenous FAK." Was this by cell sorting or merely by eye, and was the population of cells shown in Supplementary Fig. S1A ,B comprised of the same cells used for analysis, or were they separately "selected"?
8. The following statement on page 7 does not seem to make sense: "When one or two FAK molecules contained the W266A mutation...." 9. The authors need to indicate what the original sequence was that was mutated to AAATLAA, so readers can evaluate whether it may have produced major effects on molecular conformation. It is comforting, however, that the antibody-induced dimerization experiment works well.
10. It is puzzling that the FAK peak shift in Supplementary Fig S4C- E induced by FAT is not compared with the negative control using mutated FAT.
Referee #2
Brami-Cherrier et al. report in this manuscript that FAK homodimers are stabilized by both FERM-FERM and FERM-FAT domain interactions, and that dimer formation plays an essential role in FAK-kinase dependent functions. With their crystal structure information of the FERM domain and SAXS structural modeling of the full-length FAK supported by numerous other procedures, the authors provide convincing evidence that W266 within the FERM domain is essential for this dimer formation. The authors also supply suggestive evidence that interaction of FAK and Paxillin may promote homodimer formation. Overall, the results the authors have provided are significant for understanding how FAK works. There are distractions from their SPR analysis and a few other issues, however.
Specific issues identified are as follows:
SPR:
The authors show a whopping 1000-fold difference in KD values between AUC (FERM-FERM) and SPR (GST-FERM vs full-length FAK) ( Figure S2 ). Wild type FAK as analyte may selfassociate in solution, whereas W266A FAK mutant may not (for which the authors show additional data). Thus, whereas the authors estimate a 30-fold decrease in affinity in W266A FAK association to the GST-FERM fusion compared to that of wild type FAK, this is very likely overly exaggerated -the way presented in the result is misleading (in the main text, page 8). The authors should have included GST-W266A FERM domain on the chip, and use the same FAK analyte. Extremely slow rates of dissociation kinetics in the sensograms presented in Figure S2 (Figs 4, 5 and elsewhere) seem to be really problematic for estimating KD in confidence. Thus, SPR is perhaps a poor choice for their purposes. Furthermore, the authors supply their results of FAT:FERM interaction determined by ITC in Figure  S4 . Therefore, the use of Langmuir 1:1 binding model is a problem to estimate affinities between GST-FERM and full length FAK in the SPR experiments performed. Likewise, SPR experiments of GST-FERM (on chip) vs FAT (analyte) shown in Figure S4 likely have a serious inconsistency between one case where GST-FERM is on chip vs FAT as analyte and the other in which FAT on chip vs GST-FERM as analyte (more than 2 orders of magnitude; Table S2 ). Since there are multiple problems in their SPR experiments, the easiest remedy would be that the authors remove the SPR data from the manuscript. Their SPR data distract readers from the point the authors wish to convey, despite their disclaimer statements. SPR shouldn't be presented as the first panel of Figure 4 (if the authors must, move it to Figure S2 ) and should revise the text where evidence for "homodimerization of FAK" is discussed at the least.
2. Whereas the weak FERM-FERM affinity value determined by AUC (>>10 microM) seems consistent with the crystal data, it seems to be too weak to maintain dimers in solution or in the cell. Nonetheless, full-length FAK dimers seem to withstand 0.1% SDS fairly well ( Figure 4B ), whereas W266A mutation disrupts dimer formation as effectively as 1% SDS does. On the other hand, FERM-FAT interactions have a strong affinity (KD < 1 microM) determined by ITC. Does W266A affect FERM-FAT interaction in any way? 3. A similar line of question is whether FAT-FAT may self-assemble/dimerize. Figure S3C seems to suggest potential FAT-FAT interactions. This is important to test. 4. One general issue is that when the authors compare affinities, they should use the same method. In the current manuscript, affinity values are allover the scale depending on many methods they used (though SPR being the least reliable method in their estimates because of the reasons mentioned above).
5. LD4 peptide may induce an allosteric change in the FAT that enhances FERM-FAT interaction. But have the authors eliminated the possibility that LD4 peptide may bind to FERM? This would probably a negative control, but would be important to note.
6. The authors results are consistent with the possible role of paxillin-FAK binding through the LD and FAT domains, respectively, in stabilizing the FAK dimer conformation and in kinase-dependent functions of FAK. Since the authors do not have direct evidence yet, this should be stated as a hypothesis in this manuscript.
7. According to the authors model shown in Fig S3C , their kinase domains are facing outside. It may be difficult to reconcile the structure with the authors' speculation that Y397 is phosphorylated in trans within the dimer. The authors should consider a possibilities that the dimer conformation may increase its catalytic activity by allosteric changes that permit its access to ATP, for example. Thus, clustering of dimers may still be important.
Minor issues:
1. Typo in the subtitle (page 11): "Y937" must be Y397. We thank the reviewer for indicating that this point needs further clarification, which we hope to provide now in the revised version. There was indeed a decrease in the amount of W266AͲFAK at FAs, as shown in Fig. 2DͲF . The quantification of the decrease in FAK enrichment at FAs showed it was about 37% (Fig. 2F) . The previous version of lower panel in Fig. 2E probably gave an exaggerated impression concerning the decrease, which is better evaluated by the quantification. We have therefore replaced pictures in 2E lower panel by new ones, visually more representative of the mean of quantified results. At any rate, as the Referee, we were concerned that decreased enrichment of W266AͲFAK at FAs could prevent us from drawing conclusions from the acceptor photobleaching FRET experiments. This is why we included a control experiment that evaluated the change in FAK:paxillin interaction. With wt FAK we observed a significant interaction with paxillin as detected by acceptor photobleaching.
We reasoned that if the decrease in photobleaching observed with FAK originated solely from its diminished quantity at FAs we should observe also a decrease in FAK:paxillin interaction with this method. Indeed we saw, as expected, a 36% decrease (Fig. 3D) . In contrast when we carried out the same experiment with wt and W266A FAK the decrease was 80% and was highly significant (Fig. 3C) . If the decrease was due only to impaired localization, it should be similar to that observed for the paxillinͲFAK interaction. We believe that the contrast between these two results strongly argues in favor of a specific effect on FAK dimerization, in addition to the contribution of diminished concentration at FAs. The text p.7 and top of p. 8 has been modified to clarify this important point. Fig. 2F The Referee is right to point out that the decrease in FAK enrichment at FAs looks more dramatic on the pictures in Fig. 2CͲE than it appears after quantification. It is always difficult to choose pictures representatives of the "mean" and isolated images are easily misleading. This is why we prefer to rely on quantification of the FAs/cytoplasm fluorescence intensity ratio measured in individual cells. To avoid these apparent discrepancies we now illustrate the results with different pictures in Fig. 2D and 2E, more in line with the mean of quantitative data. Following the suggestion of the reviewer, we have now used as control a peptide with the same composition as the LD4 peptide but a scrambled sequence. The new experiment confirmed the previous results and showed no effect of the scrambled peptide (p. 11). These new data are now presented in Supplementary Fig. 4G and H.
Another, possibly related, inconsistency is between

The LD4 peptide experiment is quite interesting, but it is not
The section on page 8 jumping from the FERM:FERM interaction to the FAK interaction was initially quite confusing. The authors should emphasize the switch in types of molecule being studied, since it is only after reaching the conclusion on page 9 that the data showing extremely poor affinity of FERM:FERM interaction makes sense when compared to the claims of FAK:FAK dimerization, the existence of which would require considerably higher affinity. Hidden in the Discussion is an estimate for the latter of 0.1-0.5 uM, which still seems rather poor -how likely is it that one could see retention of homodimers after the long time needed for electrophoresis or gel filtration using dimers with this rather low affinity? It is possible that using a high molar concentration of FAK would help, but these concentrations are never indicated. Alternatively, is there a very low off rate? (but which would need to be accompanied by a slow on rate).
We apologize for the lack of clarity in the initial text. Following the reviewer's comments, the text has been modified on p. 8 and 9 to avoid confusion. We present first the FERM:FERM interactions, and then the interactions of the full length molecule with appropriate introductory sentences. The concentrations of FAK used for various experiments are now provided (legends to Fig. 4A, C , 5B, C, S4A, and S2A). The Referee points to a concern we also had. The difficulty is that FAK molecules are able to interact through different binding sites including FERM:FERM and FAT:FERM as shown here. As a result, when it is pure and its concentration is increased fullͲlength FAK tends to aggregate and precipitate. This unfortunate but not surprising property prevented us from using higher concentrations. In the SEC experiments we always observed a majority of monomers, in agreement with the capacity of SEC to disrupt mediumͲaffinity interactions, such as those for FAK. Also, in SEC we never observed distinct sharp peaks but rather broad overlapping peaks with distinct summits. We think that this is in agreement with the estimated affinities and the continuous formation and dissociation of dimers. The existence of several interactions between FAK molecules predicts an increase in the apparent affinity as compared to isolated domains and may lead to the formation of various combinations (including of higher order than 2). In this context we do not feel confident to make accurate predictions on the relationships between estimated affinities and experimental results in different conditions. In this context, and as requested by Referee 2 we have removed the estimates of Kd by SPR that can be misleading in terms of absolute values.
Other points: Supplementary Fig. S1A ,B comprised of the same cells used for analysis, or were they separately "selected"?
The authors should clarify how they "selected only cells for analysis that showed FAK expression levels less than 2-fold those of endogenous FAK." Was this by cell sorting or merely by eye, and was the population of cells shown in
In Fig. S1A , B we addressed the question of the expression of GFPͲFAK in transfected vs untransfected cells using a mixture of wildͲtype and transfected Ptk2 Ͳ/Ͳ cells, fixed and stained with FAK antibodies. On average the levels were about 56% higher in transfected cells (Fig. S1B ). This also allowed to visually "calibrate" the levels of GFP fluorescence that corresponded to the desired range of expression. The FRAP and liveͲ imaging experiments were done in living cells under the confocal microscope. The cells were chosen for their moderate levels of expression "by eye" based on GFP fluorescence and the same criterion was applied using the same laser power across experiments. The cells in S1A were not those which were studied by FRAP, but served for expression calibration. The procedure is now better explained p. 7 middle of bottom §.
The following statement on page 7 does not seem to make sense: "When one or two FAK molecules
contained the W266A mutation...."
We apologize for the lack of clarity in this sentence. The sentence has been changed to: "When cells were transfected with WT FAKͲmCherry and W266AͲFAKͲGFP the FRET efficiency was dramatically decreased (Ͳ80%, Fig. 3A, C) . When the transfection was done with W266AͲmCherry and W266AͲFAKͲGFP, the effect was even more pronounced (Ͳ90%, Fig. 3A, C) ."
The authors need to indicate what the original sequence was that was mutated to AAATLAA, so readers can evaluate whether it may have produced major effects on molecular conformation. It is comforting, however, that the antibody-induced dimerization experiment works well.
The wild type sequence was already indicated in the initial manuscript. However we agree that the manuscript might profit from recalling this sequence at the appropriate position. Accordingly, the sequence is now repeated p. 10 in the sentence: "We mutated the four basic residues in this cluster to alanine (K 216 AKTLRK to A 216 AATLAA). It is important that it has been shown that this mutation does not compromise the 3D structure of FERM, as demonstrated by the crystal structure of this FERM mutant (PDB 3ZDT)." Indeed the structure of this mutant FERM has been determined by XͲray crystallography (as indicated by the PDB reference) and shows no alteration in conformation. Supplementary Fig S4C- E induced by FAT is not compared with the negative control using mutated FAT.
It is puzzling that the FAK peak shift in
Of course we agree with this suggestion -however since we did not identify FAT mutations that prevent the interaction with FERM and we could not use such a mutant as a negative control. The mapping of the FERM imprint on FAT is very interesting and will be subject to future research in our groups. Figure S4 . Therefore, the use of Figure 4 (if the authors must, move it to Figure S2 ) and should revise the text where evidence for "homodimerization of FAK" is discussed at the least.
We thank the reviewer for his/her careful analysis of the SPR data. We certainly agree (as stated in our disclaimers) that the absolute SPR affinities are only 'apparent' affinities, which are affected by the limitations of this method. We had included these SPR Kds, although their absolute values can be misleading, because we considered that the relative changes between wildͲtype and mutated proteins provided useful information concerning the effects of mutations. To avoid confusion we have followed the Referee's recommendation and we have now deleted the Kd values and corresponding plots (Fig S2B, S4B and Table S2 ). We only keep the qualitative sensorgrams that clearly show major effects of mutations in Fig. 4A and 5D . According to the Referee's recommendation, 4A has been moved to supplementary Figure S2A . The Referee is right to suspect this interaction. Indeed previous and current studies in our laboratories provides evidence for a FAT: FAT interaction in vitro through a helix1Ͳ swapping dimer. However the structural changes necessary to promote the FAT:FAT interactions (opening of FAT helix1) only occur with a very low probability, and hence these FAT:FAT interactions will only become dominant at very high FAT concentrations (such as in the ones prevailing in crystallization conditions; see Arold et al. Structure, 2002) . Nonetheless, we cannot completely exclude that such an interaction contributes to some of our measurements, which is now clearly stated in the text (p. 14). Elucidating the question of FAT:FAT interaction has been of great interest to us, and we have done so in a separated study. Among other results, we show however that these FAT:FAT interactions do not appear to be relevant in vivo. Since this study includes many different experiments and authors we could not merge it with the current manuscript. Our results on FAT:FAT interactions are currently submitted for publication as a separate paper. However, following the reviewer's comments, we now mention FATͲFAT interactions in the Discussion, bottom of p. 13. As mentioned above quantitative estimates by SPR have been deleted from the manuscript, following the reviewer's suggestion.
Whereas the weak FERM-FERM
One general issue is
LD4 peptide may induce an allosteric change in the FAT that enhances FERM-FAT interaction. But have the authors eliminated the possibility that LD4 peptide may bind to FERM? This would probably a negative control, but would be important to note.
Following the referee's suggestions we have now used ITC to test the FERM:LD4 interaction. Our results show that LD4 does not interact with FERM, in agreement with previously published mapping experiments from different groups (e.g. Hildebrand et al. Mol Biol Cell, 1995) . This is now mentioned in the Results as "data not shown". I have now received comments from the original referees of your manuscript that are both satisfied with the amount of revisions and thus support publication (please see their comments below). I am thus pleased to accept your manuscript for publication here.
Please see below for important information on how to proceed. Make sure that you take the time to read the information and complete and return the necessary forms to allow us to publish your manuscript as quickly as possible. Thank you for contributing to the EMBO Journal.
-
----------------------------------REFEREE COMMENTS
Referee #1:
The authors have responded extensively and conscientiously to all of my concerns. This fine manuscript is now acceptable for publication.
Referee #2:
The revision took care of all concerns/questions I had indicated originally, and I support the case of publishing this article in the EMBO Journal. This is an important study that sheds light on to the question that has been suspected, but has not shown before this study. The title, I think, should be modified. Perhaps like: "FAK dimerization is required for its kinase-dependent functions at focal adhesions".
